Literature DB >> 158404

Vasoactive intestinal polypeptide (VIP): distribution in normal human brain and in Huntington's disease.

P C Emson, J Fahrenkrug, E G Spokes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 158404     DOI： 10.1016/0006-8993(79)91109-0

Source DB:  PubMed          Journal:  Brain Res        ISSN： 0006-8993            Impact factor:   3.252


× No keyword cloud information.
  16 in total

1.  CSF galanin and cognition after shunt surgery in normal pressure hydrocephalus.

Authors:  M Mataró; M A Poca; M Del Mar Matarín; R Catalan; J Sahuquillo; R Galard
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

2.  Vasoactive intestinal peptide in the human pituitary gland and adenomas. An immunocytochemical study.

Authors:  D W Hsu; P N Riskind; E T Hedley-Whyte
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

3.  Postmortem stability of somatostatin-like immunoreactivity in mouse brain under conditions simulating handling of human autopsy material.

Authors:  P Davies; A Thompson
Journal:  Neurochem Res       Date:  1981-07       Impact factor: 3.996

Review 4.  Alterations in neuropeptides in aging and disease. Pathophysiology and potential for clinical intervention.

Authors:  A Leake; I N Ferrier
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

5.  Cortical vasoactive intestinal peptide in relation to dementia in Parkinson's disease.

Authors:  S Jegou; F Javoy-Agid; C Delbende; M Ruberg; H Vaudry; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-08       Impact factor: 10.154

6.  Distribution of GABA and neuropeptides in the human cerebral cortex. A light and electron microscopic study.

Authors:  W Y Ong; L J Garey
Journal:  Anat Embryol (Berl)       Date:  1991

7.  Influence of vasoactive intestinal polypeptide on net water flux and cyclic adenosine 3',5'-monophosphate formation in the rat jejunum.

Authors:  E Beubler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-09       Impact factor: 3.000

8.  Suprachiasmatic nucleus neuropeptide expression in patients with Huntington's Disease.

Authors:  Daniel J van Wamelen; N Ahmad Aziz; Jasper J Anink; Robin van Steenhoven; Debora Angeloni; Franco Fraschini; Ralf Jockers; Raymund A C Roos; Dick F Swaab
Journal:  Sleep       Date:  2013-01-01       Impact factor: 5.849

Review 9.  The role of vasoactive intestinal polypeptide (VIP) as a hypothalamic neurohormone.

Authors:  S Nicosia; D Oliva; G Giannattasio; A Spada
Journal:  J Endocrinol Invest       Date:  1983-06       Impact factor: 4.256

10.  Vasoactive intestinal polypeptide and cholinergic mechanisms in cat nasal mucosa: studies on choline acetyltransferase and release of vasoactive intestinal polypeptide.

Authors:  J M Lundberg; A Anggård; P Emson; J Fahrenkrug; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.